BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33423571)

  • 1. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery.
    Samprasit W; Opanasopit P; Chamsai B
    Pharm Dev Technol; 2021 Mar; 26(3):362-372. PubMed ID: 33423571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-mangostin and resveratrol, dual-drugs-loaded mucoadhesive thiolated chitosan-based nanoparticles for synergistic activity against colon cancer cells.
    Samprasit W; Opanasopit P; Chamsai B
    J Biomed Mater Res B Appl Biomater; 2022 Jun; 110(6):1221-1233. PubMed ID: 34919783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication and In Vitro/In Vivo Performance of Mucoadhesive Electrospun Nanofiber Mats Containing α-Mangostin.
    Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Kaomongkolgit R; Opanasopit P
    AAPS PharmSciTech; 2015 Oct; 16(5):1140-52. PubMed ID: 25716329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrier.
    Yostawonkul J; Surassmo S; Iempridee T; Pimtong W; Suktham K; Sajomsang W; Gonil P; Ruktanonchai UR
    Colloids Surf B Biointerfaces; 2017 Jan; 149():301-311. PubMed ID: 27780087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of thiolated chitosan and preparation nanoparticles with sodium alginate for ocular drug delivery.
    Zhu X; Su M; Tang S; Wang L; Liang X; Meng F; Hong Y; Xu Z
    Mol Vis; 2012; 18():1973-82. PubMed ID: 22876124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
    Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
    Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
    Fan B; Xing Y; Zheng Y; Sun C; Liang G
    Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and Characterization of Mucoadhesive Buccal Nanoparticles Using Chitosan and Dextran Sulfate.
    Suh JW; Lee JS; Ko S; Lee HG
    J Agric Food Chem; 2016 Jul; 64(26):5384-8. PubMed ID: 27222213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
    Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
    Anitha A; Deepa N; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Biochim Biophys Acta; 2014 Sep; 1840(9):2730-43. PubMed ID: 24946270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers.
    Ma Y; Coombes AG
    J Biomed Mater Res A; 2014 Sep; 102(9):3167-76. PubMed ID: 24124007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoadhesive Chitosan-Pectinate Nanoparticles for the Delivery of Curcumin to the Colon.
    Alkhader E; Billa N; Roberts CJ
    AAPS PharmSciTech; 2017 May; 18(4):1009-1018. PubMed ID: 27582072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
    Xu B; Zhang W; Chen Y; Xu Y; Wang B; Zong L
    Int J Biol Macromol; 2018 Jul; 113():534-542. PubMed ID: 29408613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTH 1-34 loaded thiolated chitosan nanoparticles for osteoporosis: oral bioavailability and anabolic effect on primary osteoblast cells.
    Narayanan D; Anitha A; Jayakumar R; Chennazhi KP
    J Biomed Nanotechnol; 2014 Jan; 10(1):166-78. PubMed ID: 24724508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Eudragit® L100-coated chitosan-based nanoparticles for oral enoxaparin delivery.
    Patriota YBG; Arruda IES; de Jesus Oliveira AC; de Oliveira TC; de Lemos Vasconcelos Silva E; Chaves LL; de Oliveira Silva Ribeiro F; da Silva DA; de La Roca Soares MF; Soares-Sobrinho JL
    Int J Biol Macromol; 2021 Dec; 193(Pt A):450-456. PubMed ID: 34688680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells.
    Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannose-anchored quaternized chitosan/thiolated carboxymethyl chitosan composite NPs as mucoadhesive carrier for drug delivery.
    Jin Z; Hu G; Zhao K
    Carbohydr Polym; 2022 May; 283():119174. PubMed ID: 35153010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
    Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.